Diclegis and Ondansetron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Diclegis (doxylamine succinate; pyridoxine hydrochloride) and Ondansetron (ondansetron). Common drug interactions include gestational diabetes among females.

The phase IV clinical study analyzes what interactions people have when they take Diclegis and Ondansetron. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Diclegis?

Diclegis has active ingredients of doxylamine succinate; pyridoxine hydrochloride. eHealthMe is studying from 404 Diclegis users. Check the latest studies of Diclegis.

What is Ondansetron?

Ondansetron has active ingredients of ondansetron. It is often used in nausea. eHealthMe is studying from 122,738 Ondansetron users. Check the latest studies of Ondansetron.



On Jul, 17, 2026

11 people who take Diclegis and Ondansetron together, and have interactions are studied.

Diclegis and Ondansetron drug interactions.

What are the common drug interactions of Diclegis and Ondansetron, by gender? *:

female:

  1. Gestational diabetes (diabetes in pregnancy)
  2. Influenza
  3. Fatigue (feeling of tiredness)
  4. Impaired driving ability
  5. Maternal exposure during pregnancy (use of substance during pregnancy)
  6. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  7. Pain
  8. Pruritus (severe itching of the skin)
  9. Maternal exposure before pregnancy (use of substance before pregnancy)
  10. Pneumonia

male:

n/a

What are the common drug interactions of Diclegis and Ondansetron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Gestational diabetes (diabetes in pregnancy)
  2. Influenza
  3. Fatigue (feeling of tiredness)
  4. Impaired driving ability
  5. Pain
  6. Pruritus (severe itching of the skin)
  7. Maternal exposure before pregnancy (use of substance before pregnancy)
  8. Pneumonia
  9. Pre-eclampsia (high blood pressure and significant amounts of protein in the urine of a pregnant woman)
  10. Sinusitis (inflammation of sinus)

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 18.18%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 18.18%
  3. Humoral Immune Defect (impairment of humoral immunity): 2 people, 18.18%
  4. Drowsiness: 2 people, 18.18%
  5. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 18.18%
  6. Birth Control: 2 people, 18.18%
  7. Premature Delivery: 1 person, 9.09%
  8. Morning Sickness (sickness in morning during pregnancy): 1 person, 9.09%
  9. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Diclegis and Ondansetron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Diclegis and Ondansetron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Diclegis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ondansetron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Diclegis and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ondansetron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on doxylamine succinate; pyridoxine hydrochloride and ondansetron (the active ingredients of Diclegis and Ondansetron, respectively), and Diclegis and Ondansetron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: